Hong Kong IPOs: Lock-Up Expiries (December 2020 Edition)
There exist the "moral hazard" around the expiry of lock-up periods. In 2020, IPO's have on average underperformed the HSI heading into the lock...
561 Views
IVD Medical (華檢醫療) Trading Update - Concentrated Shareholding, Tiny Adjusted Free-Float
IVD Medical (1931 HK) raised US$131m at HK$3.07 per share, the bottom end of its IPO price range. We have previously covered the IPO in our...
507 Views
ECM Weekly (13 Jul 2019) - Budweiser APAC IPO Cancelled, Douyu Listing Next Week
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
694 Views
IVD Medical (華檢醫療) IPO Review - More than 70% of IPO Proceeds Used for Dividend and Acquisition
IVD Medical (1931 HK) (IVDM) is looking to raise up to US$157m in its upcoming IPO. IVDM is the result of the Original Group (Shanghai IVD...
563 Views
No more insights